Ahmed Mushood, Ahsan Areeba, Shafiq Aimen, Hashmi Tallal Mushtaq, Ahmed Raheel, Alam Mahboob, Shahid Farhan, Rana Jamal S, Mamas Mamas A, Fonarow Gregg C
Rawalpindi Medical University, Rawalpindi, Pakistan.
Foundation University Medical College, Islamabad, Pakistan.
J Am Geriatr Soc. 2025 Jul;73(7):2238-2246. doi: 10.1111/jgs.19447. Epub 2025 Mar 26.
Non-ST segment elevation acute coronary syndromes (NSTE-ACS) are a common cause of hospital admission in older patients. Our study aims to synthesize the available evidence from randomized controlled trials (RCTs) to compare clinical outcomes with invasive versus conservative medical management in this population.
A literature search of online databases including PubMed/MEDLINE, Embase, and the Cochrane Library was conducted from inception to September 1, 2024. The search aimed to identify RCTs that reported clinical outcomes with invasive versus conservative strategies in older patients (≥ 70 years) with NSTE-ACS. The risk ratios (RRs) were used as summary estimates.
Seven RCTs with 2998 patients were included; 1490 patients in the invasive group and 1508 patients in the conservatively managed group. The pooled analysis demonstrated no statistically significant difference between the two strategies for the risk of all-cause death (RR: 1.03, 95% CI: 0.92-1.15), cardiovascular death (RR: 1.04, 95% CI: 0.82-1.33), stroke (RR: 0.78, 95% CI: 0.53-1.15), and major bleeding (RR: 1.23, 95% CI: 0.90-1.69). However, the invasive strategy was associated with a significantly reduced risk of myocardial infarction (RR: 0.74, 95% CI: 0.57-0.96) and unplanned revascularization (RR: 0.29, 95% CI: 0.21-0.40) compared to the conservative strategy.
In older patients with NSTE-ACS, an invasive strategy reduces the risk of repeat myocardial infarction and unplanned revascularization without a significant increase in stroke or major bleeding. There was no associated reduction in all-cause or cardiovascular mortality with the invasive strategy compared to conservative management.
非ST段抬高型急性冠状动脉综合征(NSTE-ACS)是老年患者住院的常见原因。我们的研究旨在综合随机对照试验(RCT)的现有证据,比较该人群中侵入性治疗与保守药物治疗的临床结局。
对包括PubMed/MEDLINE、Embase和Cochrane图书馆在内的在线数据库进行文献检索,检索时间从数据库建立至2024年9月1日。检索旨在识别报告老年(≥70岁)NSTE-ACS患者侵入性与保守策略临床结局的RCT。风险比(RR)用作汇总估计值。
纳入了7项RCT,共2998例患者;侵入性治疗组1490例患者,保守治疗组1508例患者。汇总分析表明,两种策略在全因死亡风险(RR:1.03,95%CI:0.92-1.15)、心血管死亡风险(RR:1.04,95%CI:0.82-1.33)、中风风险(RR:0.78,95%CI:0.53-1.15)和大出血风险(RR:1.23,95%CI:0.90-1.69)方面无统计学显著差异。然而,与保守策略相比,侵入性策略与心肌梗死风险(RR:0.74,95%CI:0.57-0.96)和非计划性血管重建风险(RR:0.29,95%CI:0.21-0.40)显著降低相关。
在老年NSTE-ACS患者中,侵入性策略可降低再次心肌梗死和非计划性血管重建的风险,且不会显著增加中风或大出血风险。与保守治疗相比,侵入性策略在全因或心血管死亡率方面并无相关降低。